Su Zhen Insider Trades

Insider Trading History

Track insider trading activity for Su Zhen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $216k 59,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 59,000 shares
$2.96
$3.66
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $155k 15,508 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 15,508 shares
$8.06
$10.01
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $139k 38,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 38,000 shares
$2.82
$3.66
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $46k 4,600 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 4,600 shares
$4.48
$10.01
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $506k 50,587 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$730k 50,587 shares
$14.43
$10.01
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $139k 38,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.5k 38,000 shares
$1.96
$3.66
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $278k 76,000 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 76,000 shares
$2.27
$3.66
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $681k 68,000 shares
Last Trade
Aug 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 68,000 shares
$19.20
$10.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up